These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30387004)

  • 1. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
    Heng YJ; Wang J; Ahearn TU; Brown SB; Zhang X; Ambrosone CB; de Andrade VP; Brufsky AM; Couch FJ; King TA; Modugno F; Vachon CM; DuPre NC; Garcia-Closas M; Troester MA; Hunter DJ; Eliassen AH; Tamimi RM; Hankinson SE; Beck AH
    Breast Cancer Res Treat; 2019 Feb; 173(3):667-677. PubMed ID: 30387004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol consumption and breast tumor gene expression.
    Wang J; Heng YJ; Eliassen AH; Tamimi RM; Hazra A; Carey VJ; Ambrosone CB; de Andrade VP; Brufsky A; Couch FJ; King TA; Modugno F; Vachon CM; Hunter DJ; Beck AH; Hankinson SE
    Breast Cancer Res; 2017 Sep; 19(1):108. PubMed ID: 28899409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.
    Shieh Y; Scott CG; Jensen MR; Norman AD; Bertrand KA; Pankratz VS; Brandt KR; Visscher DW; Shepherd JA; Tamimi RM; Vachon CM; Kerlikowske K
    Breast Cancer Res; 2019 Apr; 21(1):48. PubMed ID: 30944014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose environmental radon exposure and breast tumor gene expression.
    Peng C; DuPre N; VoPham T; Heng YJ; Baker GM; Rubadue CA; Glass K; Sonawane A; Zeleznik O; Kraft P; Hankinson SE; Eliassen AH; Hart JE; Laden F; Tamimi RM
    BMC Cancer; 2020 Jul; 20(1):695. PubMed ID: 32723380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.
    Kakugawa Y; Tada H; Kawai M; Suzuki T; Nishino Y; Kanemura S; Ishida T; Ohuchi N; Minami Y
    Breast Cancer Res Treat; 2017 Feb; 162(1):115-125. PubMed ID: 28044214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index and risk of breast cancer molecular subtypes in Korean women: a case-control study.
    Jeong SH; An Y; Ahn C; Park B; Lee MH; Noh DY; Park SK
    Breast Cancer Res Treat; 2020 Jan; 179(2):459-470. PubMed ID: 31628583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in early breast cancer associated with body mass index, physical functioning, physical activity, and comorbidity: data from a nationwide Danish cohort.
    Guldberg TL; Christensen S; Zachariae R; Jensen AB
    Breast Cancer Res Treat; 2017 Feb; 162(1):159-167. PubMed ID: 28078491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of early menarche with breast tumor molecular features and recurrence.
    Harris AR; Wang T; Heng YJ; Baker GM; Le PA; Wang J; Ambrosone C; Brufsky A; Couch FJ; Modugno F; Scott CG; Vachon CM; Hankinson SE; Rosner BA; Tamimi RM; Peng C; Eliassen AH
    Breast Cancer Res; 2024 Jun; 26(1):102. PubMed ID: 38886818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective cohort study of the combined effects of physical activity and anthropometric measures on the risk of post-menopausal breast cancer.
    Bellocco R; Marrone G; Ye W; Nyrén O; Adami HO; Mariosa D; Lagerros YT
    Eur J Epidemiol; 2016 Apr; 31(4):395-404. PubMed ID: 26130128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trajectories of body mass index across the lifecourse and associations with post-menopausal breast cancer by estrogen receptor status.
    Pedersen DC; Aarestrup J; Blond K; Jensen BW; Andersen ZJ; Mellemkjær L; Tjønneland A; Baker JL
    Cancer Epidemiol; 2023 Dec; 87():102479. PubMed ID: 37897969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, mammography use and accuracy, and advanced breast cancer risk.
    Kerlikowske K; Walker R; Miglioretti DL; Desai A; Ballard-Barbash R; Buist DS
    J Natl Cancer Inst; 2008 Dec; 100(23):1724-33. PubMed ID: 19033562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor status.
    Hvidtfeldt UA; Tjønneland A; Keiding N; Lange T; Andersen I; Sørensen TI; Prescott E; Hansen ÅM; Grønbæk M; Bojesen SE; Diderichsen F; Rod NH
    Epidemiology; 2015 May; 26(3):353-61. PubMed ID: 25695354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
    Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
    Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the Role of Circulating Unconjugated Estradiol in Mediating the Body Mass Index-Breast Cancer Association.
    Schairer C; Fuhrman BJ; Boyd-Morin J; Genkinger JM; Gail MH; Hoover RN; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):105-13. PubMed ID: 26637268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
    Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
    Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study.
    Nattenmüller CJ; Kriegsmann M; Sookthai D; Fortner RT; Steffen A; Walter B; Johnson T; Kneisel J; Katzke V; Bergmann M; Sinn HP; Schirmacher P; Herpel E; Boeing H; Kaaks R; Kühn T
    BMC Cancer; 2018 May; 18(1):616. PubMed ID: 29855282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II.
    Hirko KA; Fortner RT; Hankinson SE; Wu T; Eliassen AH
    Breast Cancer Res Treat; 2016 Jul; 158(1):149-155. PubMed ID: 27294610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.